Document is current

Article History

Received: 28 August 2023

Accepted: 25 October 2023

First Online: 15 November 2023

Declarations

:

: Michael G Sension is on the Speakers Bureau for ViiV Healthcare and Gilead Sciences, and on the advisory board for ViiV Healthcare. Laurence Brunet, Jennifer S Fusco and Gregory P Fusco are employed by Epividian, Inc.; Epividian has had research funded by AIDS Healthcare Foundation, EMD Serono, Gilead Sciences, Janssen, Merck, Theratechnologies, and ViiV Healthcare. Ricky K Hsu has received research grants from Gilead Sciences, Janssen and ViiV Healthcare, speaker honoraria from ViiV Healthcare, Merck, Gilead Sciences and Janssen, and advisory board participation with ViiV Healthcare, Gilead Sciences, Janssen, and Epividian. Gayathri Sridhar, Vani Vannappagri and Jean van Wyk are employed by ViiV Healthcare and hold stocks and shares in GSK as part of their employment. Michael B Wohlfeiler has participated in post-conference advisory boards for the Conference on Retroviruses and Opportunistic Infections (CROI) and International AIDS Conference (IAC) and also serves as a principal investigator on ViiV Healthcare clinical trials but does not receive personal compensation for this work, which goes directly to the AIDS Healthcare Foundation. Michael B Wohlfeiler is also a member of the Epidemiology and Clinical Advisory Board for Epividian. Quateka Cochran, Christina Uranake and Lewis McCrudy have no conflicts of interest to declare.

: OPERA complies with all HIPAA and HITECH requirements, which expand upon the ethical principles detailed in the 1964 Declaration of Helsinki. OPERA has received annual institutional review board (IRB) approval by Advarra IRB, including a waiver of informed consent and authorization for use of protected health information (Pro00023648).